Toshiyuki Hori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Toshiyuki Hori has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
Takashi Uchiyama
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara‐cho, Sakyo‐ku, Kyoto 606‐8507, Japan
40 shared publicationsTakayuki Ishikawa
Kyoto University
9 shared publicationsAkifumi Takaori-Kondo
Kyoto University
7 shared publicationsHitoshi Sakaida
Department of Microbiology Tokyo Medical and Dental University Bunkyo‐ku Tokyo 113‐8519 Japan
5 shared publicationsNorimitsu Kadowaki
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606-8507, Japan
5 shared publicationsRimpei Morita
Department of Hematology and Oncology, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
5 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14 (1)
Immunological decoding of adult T cell leukemia – its cell of origin and oncogenesis
Adult T cell leukemia (ATL) is defined as a mature T cell neoplasm caused by human T cell leukemia virus type 1 (HTLV-1) and has been ascribed to the HTLV-1 gene products. However, the presence of asymptomatic carriers (ACs) accounting for the majority of HTLV-1 infected individuals who pass entire lives without developing ATL suggests that HTLV-1 infection alone is not sufficient for the onset of ATL. Studies with chronologically collected specimens from ATL patients or pre-onset individuals reported the presence of HTLV-1 infected CD4 + CD7 + CD45RA + T cells in blood in HTLV-1 ACs and the step wise development of malignant clones from CD7 + T cells, indicating that ATL is caused by accumulation of driver gene mutations as other cancers in general. Epidemiologically, mother-to-child infection of HTLV-1 during neonatal period is known to be the most important determinant of overall ATL incidence. This observation has attracted attention as getting to the core of the matter but has lacked hitherto any appropriate reasoning. Recent progress in basic immunology has disclosed that neonatal naïve T cells are, distinct from adult naïve T cells, exceptionally long-living and have propensity toward regulatory T cells. A minor population of stem cell like memory T cell (Tscm)-like HTLV-1 infected cells were detected in ATL patients and reported to repopulate ATL clones in immunodeficient mice. In this context, we need to trace the origin of ATL to HTLV-1 infected CD7 + T cells or Tscm in blood in ACs, and further to HTLV-1 infected neonatal naïve T cells. Latent infection of HTLV-1 has long-term effects on naïve T cells not only by viral gene products but also through their own pattern-recognition receptor-mediated reactions. In sum, the distinctive feature of ATL lies in its origin which may involve a neonatal naïve T cell and persistence of HTLV-1 provirus. The latter facilitates driver gene mutations when the infected cell increases frequency of cell division in the middle age of life.
- 2 July 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14 (1)
Open AccessImmunological decoding of adult T cell leukemia – its cell of origin and oncogenesis
Adult T cell leukemia (ATL) is defined as a mature T cell neoplasm caused by human T cell leukemia virus type 1 (HTLV-1) and has been ascribed to the HTLV-1 gene products. However, the presence of asymptomatic carriers (ACs) accounting for the majority of HTLV-1 infected individuals who pass entire lives without developing ATL suggests that HTLV-1 infection alone is not sufficient for the onset of ATL. Studies with chronologically collected specimens from ATL patients or pre-onset individuals reported the presence of HTLV-1 infected CD4 + CD7 + CD45RA + T cells in blood in HTLV-1 ACs and the step wise development of malignant clones from CD7 + T cells, indicating that ATL is caused by accumulation of driver gene mutations as other cancers in general. Epidemiologically, mother-to-child infection of HTLV-1 during neonatal period is known to be the most important determinant of overall ATL incidence. This observation has attracted attention as getting to the core of the matter but has lacked hitherto any appropriate reasoning. Recent progress in basic immunology has disclosed that neonatal naïve T cells are, distinct from adult naïve T cells, exceptionally long-living and have propensity toward regulatory T cells. A minor population of stem cell like memory T cell (Tscm)-like HTLV-1 infected cells were detected in ATL patients and reported to repopulate ATL clones in immunodeficient mice. In this context, we need to trace the origin of ATL to HTLV-1 infected CD7 + T cells or Tscm in blood in ACs, and further to HTLV-1 infected neonatal naïve T cells. Latent infection of HTLV-1 has long-term effects on naïve T cells not only by viral gene products but also through their own pattern-recognition receptor-mediated reactions. In sum, the distinctive feature of ATL lies in its origin which may involve a neonatal naïve T cell and persistence of HTLV-1 provirus. The latter facilitates driver gene mutations when the infected cell increases frequency of cell division in the middle age of life.
- Open Access
Minimal Requirements for Cancer Initiation: A Comparative Consideration of Three Prototypes of Human Leukemia
Even if its completed form is complex, cancer originates from one or two events that happened to a single cell. A simplified model can play a role in understanding how cancer initiates at the beginning. The pathophysiology of leukemia has been studied in the most detailed manner among all human cancers. In this review, based on milestone papers and the latest research developments in hematology, acute promyelocytic leukemia (APL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) with RUNX1-RUNX1T1 are selected to consider minimal requirements for cancer initiation. A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. Even in cancer cells with multiple genetic abnormalities, there must be a few mutant genes critical for the mutant clone to survive and proliferate. Such genes should be identified and characterized in each case in order to develop individualized target therapy.
Open AccessMinimal Requirements for Cancer Initiation: A Comparative Consideration of Three Prototypes of Human Leukemia
Even if its completed form is complex, cancer originates from one or two events that happened to a single cell. A simplified model can play a role in understanding how cancer initiates at the beginning. The pathophysiology of leukemia has been studied in the most detailed manner among all human cancers. In this review, based on milestone papers and the latest research developments in hematology, acute promyelocytic leukemia (APL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) with RUNX1-RUNX1T1 are selected to consider minimal requirements for cancer initiation. A one-hit model can be applied to the initiation of APL and CML whereas a two-hit model is more suitable to the initiation of AML with RUNX1-RUNX1T1 and other AMLs. Even in cancer cells with multiple genetic abnormalities, there must be a few mutant genes critical for the mutant clone to survive and proliferate. Such genes should be identified and characterized in each case in order to develop individualized target therapy.
- 20 February 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 115 (6) , 1108-1117
Differential requirement for IL-2 and IL-23 in the differentiation and effector functions of Th17/ILC3-like cells in a human T cell line
A well-documented Achilles heel of current cancer immunotherapy approaches is T cell exhaustion within solid tumor tissues. The pro-inflammatory cytokine interleukin-23 (IL-23) has been utilised to augment chimeric antigen receptor (CAR)-T cells survival and tumor immunity. However, in-depth interrogation of molecular events downstream of IL-23/IL23R signaling is hampered by a paucity of suitable cell models. The current study investigates the differential contribution of IL-2 and IL-23 to the maintenance and differentiation of the IL-23 responsive Kit225 T-cell line. We observed that IL-23 enhanced cellular fitness and survival but was insufficient to drive proliferation. IL-23 rapidly induced phosphorylation of STAT1, 3 and 4, and mRNA expression of IL17A, the archetypal effector cytokine of Th17 cells, but not their lineage markers RORC and NCR1. These observations suggest that IL-23 endowed Th17/ILC3-like effector function but did not promote their differentiation. In contrast, spontaneous differentiation of Kit225 cells towards a Th17/ILC3-like phenotype was induced by prolonged IL-2 withdrawal. This was marked by strongly elevated basal IL17A and IL17F expression and the secretion of IL-17. Together, our data present Kit225 cells as a valuable model for studying the interplay between cytokines and their contribution to T cell survival, proliferation, and differentiation.
- 20 February 2024
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 115 (6) , 1108-1117
Differential requirement for IL-2 and IL-23 in the differentiation and effector functions of Th17/ILC3-like cells in a human T cell line
A well-documented Achilles heel of current cancer immunotherapy approaches is T cell exhaustion within solid tumor tissues. The pro-inflammatory cytokine interleukin-23 (IL-23) has been utilised to augment chimeric antigen receptor (CAR)-T cells survival and tumor immunity. However, in-depth interrogation of molecular events downstream of IL-23/IL23R signaling is hampered by a paucity of suitable cell models. The current study investigates the differential contribution of IL-2 and IL-23 to the maintenance and differentiation of the IL-23 responsive Kit225 T-cell line. We observed that IL-23 enhanced cellular fitness and survival but was insufficient to drive proliferation. IL-23 rapidly induced phosphorylation of STAT1, 3 and 4, and mRNA expression of IL17A, the archetypal effector cytokine of Th17 cells, but not their lineage markers RORC and NCR1. These observations suggest that IL-23 endowed Th17/ILC3-like effector function but did not promote their differentiation. In contrast, spontaneous differentiation of Kit225 cells towards a Th17/ILC3-like phenotype was induced by prolonged IL-2 withdrawal. This was marked by strongly elevated basal IL17A and IL17F expression and the secretion of IL-17. Together, our data present Kit225 cells as a valuable model for studying the interplay between cytokines and their contribution to T cell survival, proliferation, and differentiation.
- 19 August 2019
- Published by Springer Nature in International Journal of Hematology
- Vol. 110 (5) , 591-598
BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells
In the present study, we studied downstream signals of BCR-ABL with regard to Src family kinases and YAP, a transcription cofactor and an effector of the Hippo pathway. We first checked the phosphorylation status of YAP and found that it was constitutively phosphorylated at tyrosine 357 in CML-derived cell lines (TCC-S and K562) but not in AML-derived cell lines (HL-60 and KG-1a). Treatment with imatinib or RK-20449 inhibited cell growth and decreased tyrosine phosphorylation of YAP in both CML lines. Expression of Survivin or Cyclin D1 was decreased in TCC-S, but not in either HL-60 or KG-1a. Furthermore, we established BCR-ABL stable transfectant and control empty vector transfectant from TF-1, a factor-dependent human erythroleukemia cell line, to verify our results obtained with CML cell lines. YAP was phosphorylated at Y357 constitutively in BCR-ABL stable transfectant but not in control transfectant, and treatment with imatinib or RK-20449, a Src family kinase-specific inhibitor, inhibited cell growth, YAP tyrosine phosphorylation, and expression of Cyclin D1 in BCR-ABL stable transfectant. These results suggest that BCR-ABL induces tyrosine phosphorylation of YAP presumably through Src family kinases, which results in expression of Survivin and Cyclin D leading to leukemogenesis in CML cells.
- 19 August 2019
- Published by Springer Nature in International Journal of Hematology
- Vol. 110 (5) , 591-598
BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells
In the present study, we studied downstream signals of BCR-ABL with regard to Src family kinases and YAP, a transcription cofactor and an effector of the Hippo pathway. We first checked the phosphorylation status of YAP and found that it was constitutively phosphorylated at tyrosine 357 in CML-derived cell lines (TCC-S and K562) but not in AML-derived cell lines (HL-60 and KG-1a). Treatment with imatinib or RK-20449 inhibited cell growth and decreased tyrosine phosphorylation of YAP in both CML lines. Expression of Survivin or Cyclin D1 was decreased in TCC-S, but not in either HL-60 or KG-1a. Furthermore, we established BCR-ABL stable transfectant and control empty vector transfectant from TF-1, a factor-dependent human erythroleukemia cell line, to verify our results obtained with CML cell lines. YAP was phosphorylated at Y357 constitutively in BCR-ABL stable transfectant but not in control transfectant, and treatment with imatinib or RK-20449, a Src family kinase-specific inhibitor, inhibited cell growth, YAP tyrosine phosphorylation, and expression of Cyclin D1 in BCR-ABL stable transfectant. These results suggest that BCR-ABL induces tyrosine phosphorylation of YAP presumably through Src family kinases, which results in expression of Survivin and Cyclin D leading to leukemogenesis in CML cells.
- Open Access
- 20 April 2017
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (5) , 1529-1546
TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
T follicular helper cells (Tfh) are important regulators of humoral responses. Human Tfh polarization pathways have been thus far associated with Th1 and Th17 polarization pathways. How human Tfh cells differentiate in Th2-skewed environments is unknown. We show that thymic stromal lymphopoietin (TSLP)–activated dendritic cells (DCs) promote human Tfh differentiation from naive CD4 T cells. We identified a novel population, distinct from Th2 cells, expressing IL-21 and TNF, suggestive of inflammatory cells. TSLP-induced T cells expressed CXCR5, CXCL13, ICOS, PD1, BCL6, BTLA, and SAP, among other Tfh markers. Functionally, TSLP-DC–polarized T cells induced IgE secretion by memory B cells, and this depended on IL-4Rα. TSLP-activated DCs stimulated circulating memory Tfh cells to produce IL-21 and CXCL13. Mechanistically, TSLP-induced Tfh differentiation depended on OX40-ligand, but not on ICOS-ligand. Our results delineate a pathway of human Tfh differentiation in Th2 environments.
- 20 April 2017
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 214 (5) , 1529-1546
Open AccessTSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
T follicular helper cells (Tfh) are important regulators of humoral responses. Human Tfh polarization pathways have been thus far associated with Th1 and Th17 polarization pathways. How human Tfh cells differentiate in Th2-skewed environments is unknown. We show that thymic stromal lymphopoietin (TSLP)–activated dendritic cells (DCs) promote human Tfh differentiation from naive CD4 T cells. We identified a novel population, distinct from Th2 cells, expressing IL-21 and TNF, suggestive of inflammatory cells. TSLP-induced T cells expressed CXCR5, CXCL13, ICOS, PD1, BCL6, BTLA, and SAP, among other Tfh markers. Functionally, TSLP-DC–polarized T cells induced IgE secretion by memory B cells, and this depended on IL-4Rα. TSLP-activated DCs stimulated circulating memory Tfh cells to produce IL-21 and CXCL13. Mechanistically, TSLP-induced Tfh differentiation depended on OX40-ligand, but not on ICOS-ligand. Our results delineate a pathway of human Tfh differentiation in Th2 environments.
- Open Access
- 15 August 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (4) , 1723-1731
Opposing Roles of Dectin-1 Expressed on Human Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Th2 Polarization
Dendritic cells (DCs) can induce and control host immune responses. DC subset-dependent functional specialties and their ability to display functional plasticity, which is mainly driven by signals via pattern recognition receptors, identify DCs as immune orchestrators. A pattern recognition receptor, Dectin-1, is expressed on myeloid DCs and known to play important roles in Th17 induction and activation during fungal and certain bacterial infections. In this study, we first demonstrate that human plasmacytoid DCs express Dectin-1 in both mRNA and protein levels. More interestingly, Dectin-1–activated plasmacytoid DCs promote Th2-type T cell responses, whereas Dectin-1–activated myeloid DCs decrease Th2-type T cell responses. Such contrasting outcomes of Th2-type T cell responses by the two DC subsets are mainly due to their distinct abilities to control surface OX40L expression in response to β-glucan. This study provides new insights for the regulation of host immune responses by Dectin-1 expressed on DCs.
- 15 August 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (4) , 1723-1731
Open AccessOpposing Roles of Dectin-1 Expressed on Human Plasmacytoid Dendritic Cells and Myeloid Dendritic Cells in Th2 Polarization
Dendritic cells (DCs) can induce and control host immune responses. DC subset-dependent functional specialties and their ability to display functional plasticity, which is mainly driven by signals via pattern recognition receptors, identify DCs as immune orchestrators. A pattern recognition receptor, Dectin-1, is expressed on myeloid DCs and known to play important roles in Th17 induction and activation during fungal and certain bacterial infections. In this study, we first demonstrate that human plasmacytoid DCs express Dectin-1 in both mRNA and protein levels. More interestingly, Dectin-1–activated plasmacytoid DCs promote Th2-type T cell responses, whereas Dectin-1–activated myeloid DCs decrease Th2-type T cell responses. Such contrasting outcomes of Th2-type T cell responses by the two DC subsets are mainly due to their distinct abilities to control surface OX40L expression in response to β-glucan. This study provides new insights for the regulation of host immune responses by Dectin-1 expressed on DCs.
- 15 December 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 193 (12) , 6210
Correction: Human CD141+ Dendritic Cells Induce CD4+ T Cells To Produce Type 2 Cytokines
- 15 December 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 193 (12) , 6210
Correction: Human CD141+ Dendritic Cells Induce CD4+ T Cells To Produce Type 2 Cytokines
- Open Access
- 7 January 2013
- Published by Wiley in Genes to Cells
- Vol. 18 (3) , 203-210
C. elegansRassf homolog,rasf-1, is functionally associated withrab-39Rab GTPase in oxidative stress response
The Ras association domain family (Rassf) is one of the Ras effectors, which can bind to several GTP-charged Ras-like GTPases. The Rassf proteins are widely conserved beyond species from nematode to human. To explore the novel functions of Rassf proteins, we took advantage of nematode C. elegans as a model animal with only one Rassf homolog, T24F1.3 (rasf-1). The rasf-1-mutant as well as rasf-1-knockdown animals were found to be more sensitive to oxidative stress of arsenite than in wild type, indicating that rasf-1 is involved in oxidative stress response. We next screened for proteins that interact with RASF-1 by the yeast two-hybrid system and identified RAB-39 Rab GTPase as an interacting partner of RASF-1. We not only confirmed specific binding between these molecules but also demonstrated that RASF-1 binds to GTP-bound form but not GDP-bound form of RAB-39. Importantly, rab-39 mutant animals were also sensitive to oxidative stress, which was dependent on rasf-1 according to the epistasis analysis. Moreover, Rassf1 and Rab39, mammalian homologs of rasf-1 and rab-39, respectively, were shown to interact with each other in vitro. These results indicate that the RASF-1 functionally interacts with RAB-39 and that the interaction between their homologs is conserved in mammals.
- 7 January 2013
- Published by Wiley in Genes to Cells
- Vol. 18 (3) , 203-210
Open AccessC. elegansRassf homolog,rasf-1, is functionally associated withrab-39Rab GTPase in oxidative stress response
The Ras association domain family (Rassf) is one of the Ras effectors, which can bind to several GTP-charged Ras-like GTPases. The Rassf proteins are widely conserved beyond species from nematode to human. To explore the novel functions of Rassf proteins, we took advantage of nematode C. elegans as a model animal with only one Rassf homolog, T24F1.3 (rasf-1). The rasf-1-mutant as well as rasf-1-knockdown animals were found to be more sensitive to oxidative stress of arsenite than in wild type, indicating that rasf-1 is involved in oxidative stress response. We next screened for proteins that interact with RASF-1 by the yeast two-hybrid system and identified RAB-39 Rab GTPase as an interacting partner of RASF-1. We not only confirmed specific binding between these molecules but also demonstrated that RASF-1 binds to GTP-bound form but not GDP-bound form of RAB-39. Importantly, rab-39 mutant animals were also sensitive to oxidative stress, which was dependent on rasf-1 according to the epistasis analysis. Moreover, Rassf1 and Rab39, mammalian homologs of rasf-1 and rab-39, respectively, were shown to interact with each other in vitro. These results indicate that the RASF-1 functionally interacts with RAB-39 and that the interaction between their homologs is conserved in mammals.
- Open Access
- 21 February 2011
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 208 (3) , 479-490
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
The human breast tumor microenvironment can display features of T helper type 2 (Th2) inflammation, and Th2 inflammation can promote tumor development. However, the molecular and cellular mechanisms contributing to Th2 inflammation in breast tumors remain unclear. Here, we show that human breast cancer cells produce thymic stromal lymphopoietin (TSLP). Breast tumor supernatants, in a TSLP-dependent manner, induce expression of OX40L on dendritic cells (DCs). OX40L+ DCs are found in primary breast tumor infiltrates. OX40L+ DCs drive development of inflammatory Th2 cells producing interleukin-13 and tumor necrosis factor in vitro. Antibodies neutralizing TSLP or OX40L inhibit breast tumor growth and interleukin-13 production in a xenograft model. Thus, breast cancer cell–derived TSLP contributes to the inflammatory Th2 microenvironment conducive to breast tumor development by inducing OX40L expression on DCs.
- 21 February 2011
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 208 (3) , 479-490
Open AccessThymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation
The human breast tumor microenvironment can display features of T helper type 2 (Th2) inflammation, and Th2 inflammation can promote tumor development. However, the molecular and cellular mechanisms contributing to Th2 inflammation in breast tumors remain unclear. Here, we show that human breast cancer cells produce thymic stromal lymphopoietin (TSLP). Breast tumor supernatants, in a TSLP-dependent manner, induce expression of OX40L on dendritic cells (DCs). OX40L+ DCs are found in primary breast tumor infiltrates. OX40L+ DCs drive development of inflammatory Th2 cells producing interleukin-13 and tumor necrosis factor in vitro. Antibodies neutralizing TSLP or OX40L inhibit breast tumor growth and interleukin-13 production in a xenograft model. Thus, breast cancer cell–derived TSLP contributes to the inflammatory Th2 microenvironment conducive to breast tumor development by inducing OX40L expression on DCs.
- 26 June 2009
- Published by Wiley in Microbiology and Immunology
- Vol. 53 (7) , 403-411
Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase‐A
Atrial natriuretic peptide is a cardiovascular hormone secreted mainly by the cardiac atria and regulates the volume–pressure homeostasis. The action of ANP is mediated by GC‐A. We previously reported that human monocyte‐derived dendritic cells express GC‐A and respond to ANP with polarization toward a Th2‐inducing phenotype. In the present study, we explored the possibility that pDC are subjected to immunoregulation via the ANP/GC‐A system. We examined GC‐A expression on blood pDC and found that GC‐A was not expressed on fresh pDC but was induced after stimulation with CpG‐oligodeoxynucleotide AAC‐30, IL‐3, or interleukin‐3 plus CD40 ligand. Activated pDC responded to ANP with an increase in cGMP production, indicating that GC‐A expressed on pDC was functional. We investigated whether tonsillar pDC express GC‐A by immunohistochemistry and immunofluorescence staining. We found that GC‐A+HLA‐DR+cells were present in the T‐cell areas and the perivascular areas. Flow cytometric analysis with tonsillar cells confirmed that lineage−CD123highpDC express GC‐A. These results indicate that the ANP/GC‐A system is involved in immune regulation through pDC in secondary lymphoid organs.
- 26 June 2009
- Published by Wiley in Microbiology and Immunology
- Vol. 53 (7) , 403-411
Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase‐A
Atrial natriuretic peptide is a cardiovascular hormone secreted mainly by the cardiac atria and regulates the volume–pressure homeostasis. The action of ANP is mediated by GC‐A. We previously reported that human monocyte‐derived dendritic cells express GC‐A and respond to ANP with polarization toward a Th2‐inducing phenotype. In the present study, we explored the possibility that pDC are subjected to immunoregulation via the ANP/GC‐A system. We examined GC‐A expression on blood pDC and found that GC‐A was not expressed on fresh pDC but was induced after stimulation with CpG‐oligodeoxynucleotide AAC‐30, IL‐3, or interleukin‐3 plus CD40 ligand. Activated pDC responded to ANP with an increase in cGMP production, indicating that GC‐A expressed on pDC was functional. We investigated whether tonsillar pDC express GC‐A by immunohistochemistry and immunofluorescence staining. We found that GC‐A+HLA‐DR+cells were present in the T‐cell areas and the perivascular areas. Flow cytometric analysis with tonsillar cells confirmed that lineage−CD123highpDC express GC‐A. These results indicate that the ANP/GC‐A system is involved in immune regulation through pDC in secondary lymphoid organs.